By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Thermo Fisher Scientific today reported a 7 percent increase in revenues year over year and a nearly 15 percent increase in profits for its second quarter.

For the three months ended July 3, the company posted receipts of $2.65 billion, up from $2.48 billion in Q2 2009. The firm fell just short of analysts' consensus estimate of $2.66 billion.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

The New York Times' George Johnson muses on cancer's roots in multicellularity.

The San Diego Union Tribune wonders whether Medicare is ready for personalized medicine.

Jun Wang, the chief executive of BGI, has stepped down.

In PNAS this week: human T cell editing with CRISPR, retrotransposons acting as insulators, and more.